Bunavail is among numerous medications that help alleviate the drug cravings and withdrawal symptoms that arise during the initial stages of opioid use disorder (OUD) recovery and detoxification. Bunavail is administered as part of medically-assisted detoxification.

Like other drugs employed to support addiction recovery, Bunavail does not serve as the sole treatment for addiction. Instead, it constitutes one element of a comprehensive treatment approach that addresses the multifaceted issues associated with addiction.

About Bunavail

Bunavail is a medication brand that comprises buprenorphine and naloxone.

Buprenorphine is an opioid that has specific pharmacological characteristics that make it a suitable candidate for opioid substitution therapy. It blocks other opioids from attaching to the receptors in the brain and has minimal opioid activity, reducing the risk of euphoria and overdose.

The addition of naloxone to buprenorphine in Bunavail enhances its efficacy by serving as an opioid blocker, thereby blocking the effects of opioids, and preventing opioid abuse.

Unlike other pharmaceutical buprenorphine-naloxone combinations, Bunavail is unique in its small, dissolvable strip format, making it easier to administer.

Bunavail vs. Suboxone treatment: Which is better for opioid dependence?

The Bunavail Buccal Film has superior bioavailability compared to Suboxone, with twice the concentration of buprenorphine. The BEMA technology used in Bunavail facilitates better absorption of buprenorphine, allowing for similar plasma levels of buprenorphine as Suboxone with just half the dose of Bunavail. This improvement is advantageous as it reduces the likelihood of drug misuse and diversion while also potentially mitigating some of the side effects of buprenorphine.

Who should take Bunavail treatment?

Bunavail is a treatment option recommended for adults above 18 years with OUD. It is meant to be used as part of an all-inclusive opioid addiction treatment plan and not as a standalone therapy.

Bunavail is suitable for outpatient and office-based management, making it a valuable option for individuals undergoing outpatient treatment or transitioning from a residential or inpatient rehab program.

Who shouldn’t take Bunavail treatment?

Bunavail is strictly for the treatment of Opioid Use Disorder and should not be used for pain management. Its side effects can be severe and even fatal if taken in combination with benzodiazepines or other central nervous system depressants, including alcohol.

People taking Bunavail must inform their prescriber of their medications and consider some precautions: those with liver impairment must not take Bunavail without clearance from their doctor, it should not be used by pregnant or breastfeeding women, children, or until the onset of withdrawal effects or a prescribed period has passed since the last dose.

How long does Bunavail take to block opiates?

Starting Bunavail too early can cause the quick onset of withdrawal symptoms due to naloxone’s fast-acting properties, while buprenorphine takes three to four hours to reach peak levels in the blood and relieve withdrawal symptoms. The half-lives of Bunavail’s active ingredients, buprenorphine, and naloxone, differ with buprenorphine lasting 16.4 to 27.5 hours and naloxone lasting 1.9 to 2.4 hours.

For a drug to be eliminated from the body, it takes six to seven half-lives, which means it takes three to five days for buprenorphine to reach low enough levels to cause withdrawal symptoms.

With these important points, we hope your Bunavail treatment for opioid dependence goes smoothly.

If you are looking for Bunavail treatment in Spartanburg, come to Clear Skye Treatment Centers.